Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Aggeliki Panagiotou"'
Autor:
Ilias Samiotis, Ioannis Stamatatos, Despoina Mylonaki, Nikolaos Tzatzadakis, Stylianos Zaragkas, Dimitris Lioumpas, Konstantinos Boumpoulis, Aggeliki Panagiotou
Publikováno v:
Thoracic Surgery.
Background: Hepatic hydrothorax is a complication of end-stage liver disease. Approximately 22% of cases are refractory to salt, fluid restriction and diuretics, thus posing a challenging therapeutic dilemma due its rapid symptomatic recurrence. This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a5d5d28b9383f2dcbfc5a6b729df6c0
https://doi.org/10.1183/13993003.congress-2018.pa2570
https://doi.org/10.1183/13993003.congress-2018.pa2570
Autor:
Stylianos Zaragkas, Dimitris Lioumpas, Ioannis Stamatatos, Ilias Samiotis, Despoina Mylonaki, Kostantinos Bouboulis, Aggeliki Panagiotou, Nikolaos Tzatzadakis
Publikováno v:
Thoracic Surgery.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd81e8f83b5b2b6e78973f7f613f6e78
https://doi.org/10.1183/13993003.congress-2018.pa2567
https://doi.org/10.1183/13993003.congress-2018.pa2567
Autor:
Costas Fourtounas, Aggeliki Panagiotou
Publikováno v:
General Medicine: Open Access.
Thrombotic cardiovascular events are one of the main causes of morbidity and mortality in dialysis patients [1] and vascular access thrombosis remains the Achilles’ heel for patients undergoing maintenance hemodialysis (HD) [2]. HD and uremia are c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc8f4c843541d3683af8e4b75f15f77d
https://doi.org/10.4172/2327-5146.1000109
https://doi.org/10.4172/2327-5146.1000109
Autor:
Aggeliki Panagiotou, Ioanna Xanthopoulou, Periklis Davlouros, Grigorios Tsigkas, Dimitrios Alexopoulos, Georgios Hahalis
Publikováno v:
The Canadian journal of cardiology. 27(6)
Absrtact Background The long-term clinical outcome of patients with previous coronary artery bypass grafting (CABG), undergoing percutaneous coronary intervention (PCI) is not clear. Methods Observational, retrospective study of post-CABG patients, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::744c3ade97f4757470355a8925f91d2b
https://pubmed.ncbi.nlm.nih.gov/22019279
https://pubmed.ncbi.nlm.nih.gov/22019279
Autor:
George Hahalis, Aggeliki Panagiotou, Panagiota Mylona, Ioanna Xanthopoulou, Angelos Perperis, Gerasimos Dimitropoulos, Periklis Davlouros, Grigorios Tsigkas, Dimitrios Alexopoulos
Publikováno v:
Journal of thrombosis and thrombolysis. 32(3)
The prevalence of prasugrel contraindications and specific conditions requiring precaution for its use in a real world acute coronary syndrome (ACS) population is not known. We performed a prospective descriptive study in 1016 consecutive moderate to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1db47878f480f68ba73c0f03fbc7b326
https://pubmed.ncbi.nlm.nih.gov/21681393
https://pubmed.ncbi.nlm.nih.gov/21681393
Autor:
Dimitrios Alexopoulos, Eleni Mavronasiou, Aggeliki Panagiotou, Theodora-Eleni Plakomyti, Ioanna Xanthopoulou, Periklis Davlouros, George Hahalis
Publikováno v:
American heart journal. 162(4)
High on-treatment platelet reactivity (HTPR) is present in a substantial percentage of patients on chronic clopidogrel treatment and may have prognostic implications. Strategies to optimize platelet inhibition in such patients are not clear.We perfor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da0a91c54ab487047f67fc43121d5b2a
https://pubmed.ncbi.nlm.nih.gov/21982667
https://pubmed.ncbi.nlm.nih.gov/21982667